Adam Brufsky, MD, PhD

UPMC Hillman Cancer Center

Latest Content

An informative graphic featuring Dr. Sara Tolaney, Dr. Adam Brufsky, Dr. Rahul Gosain, and Dr. Rohit Gosain discussing the use of CDK4/6 inhibitors in HR+ breast cancer cases.

Breast Cancer

11/24/2025

Assessing CDK4/6 Inhibitor Use in HR+ Breast Cancer Cases

Sara Tolaney, MD, MPHAdam Brufsky, MD, PhDRohit Gosain, MDRahul Gosain, MD, MBA